Pharmaceutical

Gilead, CHAI and Penta to enhance HIV treatment for children

Gilead Sciences has entered into collaborations with CHAI and Penta ID network to expedite the development of dispersible HIV treatments.

Jul 15, 2023 - 20:00
Gilead, CHAI and Penta to enhance HIV treatment for children
Gilead Sciences has entered into collaborations with CHAI and Penta ID network to expedite the development of dispersible HIV treatments.
Read the original article

Tags:

Previous Article

Vistagen obtains Canadian Notice of Allowance for AV-101 patent

Next Article

Health Canada approves AstraZeneca-Merck’s prostate cancer therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Johnson & Johnson acquires Ambrx Biopharma for $2bn

Johnson & Johnson acquires Ambrx Biopharma for $2bn

Mar 9, 2024

STAT+: Michigan bill that would pare back pharma liability shield law moves closer to enactment

STAT+: Michigan bill that would pare back pharma liabil...

Nov 13, 2023

STAT+: Eli Lilly, riding a hot streak, expects to double planned employment in Boston research center

STAT+: Eli Lilly, riding a hot streak, expects to doubl...

Oct 20, 2023